The Lead Episode 100: A Discussion of Subcutaneous Implantable Defibrillators in Young Patients: Arrhythmias, Complications, and Physical Activity, LIVE from EHRA 2025 in Vienna-The Lead Episode 100 Speaker Information

The Lead Episode 100 Speaker Information

Pdf Summary

The discussion hosted by Michael S. Lloyd, MD, FHRS, at the EHRA 2025 conference in Vienna, focused on a critical study titled "Subcutaneous Implantable Defibrillators in Young Patients: Arrhythmias, Complications, and Physical Activity." This study is published in the journal Circulation: Arrhythmia and Electrophysiology and authored by a team of experts headed by Pietro Francia, MD, among others.<br /><br />The conversation was enriched by contributions from Reinoud Knops, MD, PhD, of Amsterdam University Medical Center, and Karim Benali, MD, PhD, from Saint-Etienne University Hospital. Both experts provided insights into the implications of using subcutaneous implantable defibrillators (S-ICDs) in young patients, particularly concerning arrhythmias, associated complications, and considerations around physical activity post-implementation.<br /><br />S-ICDs are essential devices for preventing sudden cardiac arrest in patients at risk. Unlike traditional transvenous ICDs, S-ICDs are implanted subcutaneously, which can significantly reduce infection risks and procedural complications associated with leads inserted into the heart through veins. The discussion highlighted the balance between the benefits of implanting such devices in younger populations against potential complications they may face over time, including mechanical issues and the psychological impact on young patients' lifestyles.<br /><br />Both Lloyd and his contributors disclosed affiliations with companies like Medtronic, Boston Scientific, and others, affirming the industry's prevalent collaboration for advancing medical technologies. The expert opinions and experiences shared in the discussion are invaluable for understanding the complexities and decision-making processes involved in treating young patients with arrhythmias using S-ICDs. The session was a platform to discuss innovations, clinical outcomes, and shared practices for optimizing patient care and improving life quality in individuals with high arrhythmogenic profiles.

Keywords

EHRA 2025

subcutaneous implantable defibrillators

young patients

arrhythmias

physical activity

Michael S. Lloyd

Pietro Francia

Reinoud Knops

Karim Benali

Circulation: Arrhythmia and Electrophysiology